The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies

被引:12
|
作者
Calik, Sebnem [1 ]
Ari, Alpay [1 ]
Bilgir, Oktay [2 ]
Cetintepe, Tugba [2 ]
Yis, Reyhan [3 ]
Sonmez, Ufuk [1 ]
Tosun, Selma [1 ]
机构
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
[2] Univ Hlth Sci, Dept Hematol, Izmir, Turkey
[3] Univ Hlth Sci, Dept Microbiol & Clin Microbiol, Izmir, Turkey
关键词
BLOOD-STREAM INFECTIONS; CANCER; MANAGEMENT; FEVER; EPIDEMIOLOGY; COMBINATION; GUIDELINES; AMIKACIN; THERAPY; TRIAL;
D O I
10.15537/smj.2018.9.22824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine effective risk factors on mortality in febrile neutropenic cases with hematologic malignancy. Patients with hematologic diseases are more prone to infections and those are frequent causes of mortality. Methods: This retrospective study was performed using data of 164 febrile neutropenic cases with hematologic malignancies who were followed up in a hematology clinic of a tertiary health care center between 2011-2015. The relationship between descriptive and clinical parameters rates and rates of mortality on the 7th and the 21st days were investigated. Results: Patients with absolute neutrophil count<100/mm(3), duration of neutropenia longer than 7 days, pneumonia or gastrointestinal foci of infection, central catheterization (p=0.025), isolation of Gram (-) bacteria in culture, carbapenem resistance, septic shock, and bacterial growth during intravenous administration of antibiotic treatment were under more risk for mortality on both the 7th and the 21st days. The final multivariate logistic regression results showed that pneumonia (p<0.0001), septic shock (p=0.004) and isolation of Gram-negative bacteria (p=0.032) were statistically significant risk factors. Conclusion: Early diagnosis and appropriate treatment of serious infections, which are important causes of morbidity and mortality, are crucial in patients with febrile neutropenia. Thus, each center should closely follow up causes of infection and establish their empirical antibiotherapy protocols to accomplish better results in the management of febrile neutropenia.
引用
收藏
页码:878 / 885
页数:8
相关论文
共 50 条
  • [1] Reassessment of Recommended Imipenem Doses in Febrile Neutropenic Patients with Hematological Malignancies
    Lamoth, F.
    Buclin, T.
    Csajka, C.
    Pascual, A.
    Calandra, T.
    Marchetti, O.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 785 - 787
  • [2] Efficacy and safety of Micafungin in Febrile Neutropenic Patients Treated for Hematological Malignancies
    Toubai, Tomomi
    Tanaka, Junji
    Ota, Shuichi
    Shigematsu, Akio
    Shono, Yusuke
    Ibata, Makoto
    Hashino, Satoshi
    Kondo, Takeshi
    Kakinoki, Yasutaka
    Masauzi, Nobuo
    Kasai, Masaharu
    Iwasaki, Hiroshi
    Kurosawa, Mitsutoshi
    Asaka, Masahiro
    Imamura, Masahiro
    INTERNAL MEDICINE, 2007, 46 (01) : 3 - 9
  • [3] USING TEICOPLANIN FOR EMPIRIC THERAPY OF FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    MENICHETTI, F
    DELFAVERO, A
    BUCANEVE, G
    AVERSA, F
    FIORIO, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 : 45 - 48
  • [4] Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies
    Isobe, Yasushi
    Kanemitsu, Naoko
    Yahata, Yuriko
    Masuda, Azuchi
    Tsukune, Yutaka
    Sugimoto, Koichi
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (03) : 237 - 239
  • [5] Investigating the presence of fungal agents in febrile neutropenic patients with hematological malignancies using different microbiological, serological, and molecular methods
    Sonmez, Ahu
    Eksi, Fahriye
    Pehlivan, Mustafa
    Sahin, Handan Haydaroglu
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 15 (03) : 40 - 47
  • [6] Relationship between leukopenia and mortality among patients with hematological malignancies
    Caibao Hu
    Qian Li
    Xinyuan Ding
    Critical Care, 28 (1):
  • [7] TIMENTIN IN COMBINATION WITH TOBRAMYCIN AS EMPIRICAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    KRIEGER, O
    BERNHART, M
    PLOHOWICH, R
    NEMEC, H
    LUTZ, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 211 - 217
  • [8] The Evaluation of Nasal Cultures in Patients with Hematological Malignancies During Febrile Neutropenic Episodes
    Ulug, Mehmet
    Ayaz, Celal
    Celen, Mustafa Kemal
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2012, 50 (04): : 136 - 141
  • [9] Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
    Islas-Munoz, Beda
    Volkow-Fernandez, Patricia
    Silva-Zamora, Jorge
    Ramirez-Ibarguen, Ana
    Cornejo-Juarez, Patricia
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (02): : 235 - 242
  • [10] Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies
    Ahmad Baraka
    Marwa Zakaria
    International Journal of Hematology, 2018, 108 : 184 - 191